GE

Gabriela Ecco

Life sciences investor at +ND Capital

Lausanne, Vaud

Invests in

Locations:

  • Min Investment:

    $100,000.00
  • Max Investment:

    $5,000,000.00
  • Target Investment:

    $1,500,000.00

Work Experience

  • Principal

    2025

  • Senior Associate

    2023 - 2025

  • Associate

    2021 - 2022

  • Innovation Fellow

    2021 - 2021

  • Board Observer

    2025

  • Board Observer

    2024

  • Board Observer

    2023

2022

  • Board Observer

    2022

2021

  • Board Observer

    2021

  • Board Observer

    2021

  • Board Observer

    2022 - 2025

2021 - 2022

  • Board Observer

    2021 - 2022

2016 - 2021

  • Genomics Research Expert

    2020 - 2021

    - Led different R&D projects to develop next generation sequencing (NGS) products for precision medicine and molecular diagnostics in oncology.

  • Senior NGS Scientist

    2019 - 2020

    - Led different R&D projects to develop next generation sequencing (NGS) products for precision medicine and molecular diagnostics in oncology.

  • NGS Scientist

    2016 - 2019

    - Coordinated and participated in different projects to develop products for precision medicine and molecular diagnostics in oncology. - Performed on-site customer trainings in Europe and South America and provided internal and external technical support.